Theravance Biopharma (NASDAQ:TBPH) Rating Increased to Buy at StockNews.com
Theravance Biopharma (NASDAQ:TBPH – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Wednesday. Separately, HC Wainwright reissued a “buy” rating and set a $15.00 price objective on shares of Theravance Biopharma in a research note on Tuesday, February […]
